Discontinued — last reported Q2 '24
Non-Current Assets
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)
Medtronic Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) increased by 7.2% to $3.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $3.26B to $3.12B.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2021
Last reportedQ2 2024
Metric ID:
afs_debt_securities_fair_value_maturing_1_to_5yHistorical Data
6 periods
| Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $3.43B | $3.32B | $3.26B | $3.04B | $2.91B | $3.12B |
| QoQ Change | — | -3.2% | -2.0% | -6.8% | -4.2% | +7.2% |
| YoY Change | — | — | — | -11.5% | -12.5% | -4.3% |
Range$2.91B – $3.43B
CAGR-7.4%
Avg YoY Growth-9.4%
Median YoY Growth-11.5%
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) at Other Companies
Frequently Asked Questions
- What is Medtronic's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Medtronic (MDT) reported available-for-sale debt securities - fair value (maturing 1 to 5 years) of $3.12B in Q1 2026.
- How has Medtronic's available-for-sale debt securities - fair value (maturing 1 to 5 years) changed year-over-year?
- Medtronic's available-for-sale debt securities - fair value (maturing 1 to 5 years) decreased by 4.3% year-over-year, from $3.26B to $3.12B.